ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,352, issued on May 27, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).
"Use of a DPP-4 inhibitor in SIRS and/or sepsis" was invented by Thomas Klein (Radolfzell, Germany), Andreas Daiber (Scheessel, Germany), Klaus Dugi (Dresden, Germany), Michael Mark (Biberach an der Riss, Germany) and Thomas Muenzel (Mainz, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for treating and/or preventing SIRS and/or sepsis comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preven...